These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 18073375)
1. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. Duggan D; Zheng SL; Knowlton M; Benitez D; Dimitrov L; Wiklund F; Robbins C; Isaacs SD; Cheng Y; Li G; Sun J; Chang BL; Marovich L; Wiley KE; Bälter K; Stattin P; Adami HO; Gielzak M; Yan G; Sauvageot J; Liu W; Kim JW; Bleecker ER; Meyers DA; Trock BJ; Partin AW; Walsh PC; Isaacs WB; Grönberg H; Xu J; Carpten JD J Natl Cancer Inst; 2007 Dec; 99(24):1836-44. PubMed ID: 18073375 [TBL] [Abstract][Full Text] [Related]
2. Genetic and biologic evidence that implicates a gene in aggressive prostate cancer. Hsieh JT; Karam JA; Min W J Natl Cancer Inst; 2007 Dec; 99(24):1823-4. PubMed ID: 18073373 [No Abstract] [Full Text] [Related]
3. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536 [TBL] [Abstract][Full Text] [Related]
4. Replication of prostate cancer risk loci in a Japanese case-control association study. Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753 [TBL] [Abstract][Full Text] [Related]
5. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. Sun J; Purcell L; Gao Z; Isaacs SD; Wiley KE; Hsu FC; Liu W; Duggan D; Carpten JD; Grönberg H; Xu J; Chang BL; Partin AW; Walsh PC; Isaacs WB; Zheng SL Prostate; 2008 May; 68(7):691-7. PubMed ID: 18361410 [TBL] [Abstract][Full Text] [Related]
6. Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men. Bangsi D; Zhou J; Sun Y; Patel NP; Darga LL; Heilbrun LK; Powell IJ; Severson RK; Everson RB Urol Oncol; 2006; 24(1):21-7. PubMed ID: 16414488 [TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans. Bensen JT; Xu Z; Smith GJ; Mohler JL; Fontham ET; Taylor JA Prostate; 2013 Jan; 73(1):11-22. PubMed ID: 22549899 [TBL] [Abstract][Full Text] [Related]
8. Association of testis derived transcript gene variants and prostate cancer risk. Liu X; Cicek MS; Plummer SJ; Jorgenson E; Casey G; Witte JS J Urol; 2007 Mar; 177(3):894-8. PubMed ID: 17296370 [TBL] [Abstract][Full Text] [Related]
9. A common genetic variant (97906C>A) of DAB2IP/AIP1 is associated with an increased risk and early onset of lung cancer in Chinese males. Yang L; Li Y; Ling X; Liu L; Liu B; Xu K; Bin X; Ji W; Lu J PLoS One; 2011; 6(10):e26944. PubMed ID: 22046421 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer risk associated loci in African Americans. Xu J; Kibel AS; Hu JJ; Turner AR; Pruett K; Zheng SL; Sun J; Isaacs SD; Wiley KE; Kim ST; Hsu FC; Wu W; Torti FM; Walsh PC; Chang BL; Isaacs WB Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2145-9. PubMed ID: 19549807 [TBL] [Abstract][Full Text] [Related]
11. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. Salinas CA; Kwon E; Carlson CS; Koopmeiners JS; Feng Z; Karyadi DM; Ostrander EA; Stanford JL Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1203-13. PubMed ID: 18483343 [TBL] [Abstract][Full Text] [Related]
12. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779 [TBL] [Abstract][Full Text] [Related]
13. Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma. Kibel AS; Ahn J; Isikbay M; Klim A; Wu WS; Hayes RB; Isaacs WB; Daw EW Prostate; 2016 Apr; 76(5):479-90. PubMed ID: 26708993 [TBL] [Abstract][Full Text] [Related]
14. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Agalliu I; Kwon EM; Salinas CA; Koopmeiners JS; Ostrander EA; Stanford JL Cancer Causes Control; 2010 Feb; 21(2):289-300. PubMed ID: 19902366 [TBL] [Abstract][Full Text] [Related]
15. Association of CD14 variant with prostate cancer in African American men. Mason TE; Ricks-Santi L; Chen W; Apprey V; Joykutty J; Ahaghotu C; Kittles R; Bonney G; Dunston GM Prostate; 2010 Feb; 70(3):262-9. PubMed ID: 19830784 [TBL] [Abstract][Full Text] [Related]
16. EphB2 SNPs and sporadic prostate cancer risk in African American men. Robbins CM; Hooker S; Kittles RA; Carpten JD PLoS One; 2011; 6(5):e19494. PubMed ID: 21603658 [TBL] [Abstract][Full Text] [Related]
17. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort. Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411 [TBL] [Abstract][Full Text] [Related]
18. Prostate cancer susceptibility Loci identified on chromosome 12 in African Americans. Bonilla C; Hooker S; Mason T; Bock CH; Kittles RA PLoS One; 2011 Feb; 6(2):e16044. PubMed ID: 21358824 [TBL] [Abstract][Full Text] [Related]
19. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291 [TBL] [Abstract][Full Text] [Related]
20. Interactions of Lin HY; Callan CY; Fang Z; Tung HY; Park JY Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1067-1075. PubMed ID: 30914434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]